PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-3.88%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.31B
AUM Growth
+$1.31B
(-25%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-22.54%
Top 10 Holdings %
Top 10 Hldgs %
50.96%
Holding
96
New
18
Increased
9
Reduced
25
Closed
19
Top Buys
| 1 |
DexCom
DXCM
|
$25.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
$22.8M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$21.7M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$18.9M |
| 5 |
United Therapeutics
UTHR
|
$18.5M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$92.8M |
| 2 |
Merck
MRK
|
$61.6M |
| 3 |
Acadia Healthcare
ACHC
|
$43.5M |
| 4 |
Elevance Health
ELV
|
$29.3M |
| 5 |
Amgen
AMGN
|
$29.1M |
Sector Composition
| 1 | Healthcare | 92.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $231M | 14.29% | 298,643 | – | – |
|
2
Tenet Healthcare
THC
$16.3B
| $62M | 3.84% | 491,334 -98,075 | -17% | -$12.4M |
|
3
AbbVie
ABBV
$372B
| $59M | 3.65% | 331,741 -72,120 | -18% | -$12.8M |
|
4
McKesson
MCK
$85.4B
| $55.6M | 3.44% | 97,498 | – | – |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $51.1M | 3.17% | 126,989 -21,863 | -15% | -$8.8M |
|
6
Intuitive Surgical
ISRG
$170B
| $48.6M | 3.01% | 93,073 -44,254 | -32% | -$23.1M |
|
7
Edwards Lifesciences
EW
$47.8B
| $44M | 2.73% | 594,172 +203,309 | +52% | +$15.1M |
|
8
Axsome Therapeutics
AXSM
$6.05B
| $39.5M | 2.45% | 467,427 | – | – |
|
9
Penumbra
PEN
$10.6B
| $39.5M | 2.45% | 166,261 | – | – |
|
10
argenx
ARGX
$43.6B
| $39.2M | 2.43% | 63,699 -23,133 | -27% | -$14.2M |
|
11
Universal Health Services
UHS
$11.6B
| $38.4M | 2.38% | 213,983 | – | – |
|
12
UnitedHealth
UNH
$281B
| $38.2M | 2.37% | 75,588 | – | – |
|
13
Danaher
DHR
$147B
| $28.8M | 1.79% | 125,515 | – | – |
|
14
Icon
ICLR
$13.8B
| $27M | 1.67% | 128,637 +12,105 | +10% | +$2.54M |
|
|
15
DexCom
DXCM
$29.5B
| $25.6M | 1.58% | +328,763 | New | +$25.6M |
|
|
16
Neurocrine Biosciences
NBIX
$13.8B
| $22.8M | 1.41% | +166,803 | New | +$22.8M |
|
17
IQVIA
IQV
$32.4B
| $22M | 1.36% | 111,854 | – | – |
|
18
Waters Corp
WAT
$18B
| $21.9M | 1.36% | 59,053 +7,990 | +16% | +$2.96M |
|
|
19
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $21.7M | 1.34% | +347,637 | New | +$21.7M |
|
20
Humana
HUM
$36.5B
| $21.1M | 1.31% | 83,037 -18,917 | -19% | -$4.8M |
|
21
HCA Healthcare
HCA
$94.5B
| $20.8M | 1.29% | 69,441 -55,399 | -44% | -$16.6M |
|
22
Molina Healthcare
MOH
$9.8B
| $20.4M | 1.26% | 70,088 | – | – |
|
|
23
Invesco S&P 500 Equal Weight ETF
RSP
$74.2B
| $18.9M | 1.17% | +108,041 | New | +$18.9M |
|
|
24
United Therapeutics
UTHR
$13.8B
| $18.5M | 1.15% | +52,500 | New | +$18.5M |
|
25
Cardinal Health
CAH
$35.5B
| $17.5M | 1.09% | +148,173 | New | +$17.5M |
|